首页 › 食管癌 › 纽约州 › New York City
New York City NY 食管癌临床试验
22项针对 食管癌的研究正在 New York City及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本(英文)
正在为研究招募参与者?将此页面置顶展示 — $99 / 30天 →
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
招募中1 期
- NYU Langone Medical Center - Perlmutter Cancer Center (NYU Cancer Institute), New York
- NYU Langone Medical Center - Perlmutter Cancer Center (NYU Cancer Institute), New York
- Icahn School of Medicine at Mount Sinai, New York
- 以及另外 2 项
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
招募中观察性研究欢迎健康志愿者
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
招募中2 期
- Memorial Sloan Kettering Hospital, New York
A Study of Pembrolizumab With Trastuzumab and Chemotherapy in People With Esophagogastric Cancer
招募中2 期
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
招募中1 期
- New York University (NYU) Langone Medical Center, New York
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
招募中1 期
- New York University (NYU) Clinical Cancer Center, New York
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
招募中1/2 期
- Columbia University, New York
- NYU Langone Health, New York
- Memorial Sloan Kettering Cancer Center, New York
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
招募中1 期
- Memorial Sloan Kettering Cancer Center Head Neck Services, New York
Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer.
招募中3 期
- Icahn School of Medicine at Mount Sinai, New York
- Memorial Sloan Kettering Cancer Center, New York
A Study of 2141-V11 in People With Esophageal, Gastric, or Gastroesophageal Junction Adenocarcinoma
招募中1/2 期
- Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
招募中1 期
- Laura & Isaac Perlmutter Cancer Center at NYU Langone Health, New York
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
招募中3 期
- Research Site, New York
- Research Site, New York
- Research Site, New York
Retrospective Review of Esophageal Cancer at MSKCC
招募中观察性研究
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
招募中1 期
- Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York
Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma
招募中观察性研究欢迎健康志愿者
- Columbia University Medical Center, New York
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
招募中1/2 期
- Mt. Sinai, New York
- Memorial Sloan Kettering Cancer Center, New York
A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
招募中2 期
- Memorial Sloan Kettering Cancer Center, New York
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
招募中1 期
- North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, New York
- Columbia University Irving Medical Center, New York
Registry for Esophageal and Gastroesophageal Junction Cancer
招募中观察性研究
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Brodalumab in the Treatment of Immune-Related Adverse Events
招募中1 期
- Columbia University Irving Medical Center, New York
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
招募中1/2 期
- Weill Cornell Medicine, Cornell University (site 126), New York
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中观察性研究
- Massive Bio SYNERGY-AI site, New York
其他城市的 食管癌试验
- Houston, TX36 项研究
- Boston, MA23 项研究
- Nashville, TN19 项研究
- St. Louis, MO17 项研究
- Pittsburgh, PA15 项研究
- Los Angeles, CA15 项研究
- Baldwin Park, CA14 项研究
- Grand Rapids, MI14 项研究
- Philadelphia, PA13 项研究
- San Antonio, TX12 项研究
- Arlington, VA11 项研究
- Rochester, MN11 项研究
New York City的其他研究
- 乳腺癌136 项研究
- 非小细胞肺癌121 项研究
- 癌症(所有类型)109 项研究
- 前列腺癌103 项研究
- 转移性癌症93 项研究
- 结直肠癌78 项研究
- 卵巢癌69 项研究
- 肺癌60 项研究
- 多发性骨髓瘤60 项研究
- 胰腺癌60 项研究
- 子宫内膜癌52 项研究
- 急性髓系白血病51 项研究
数据来自 ClinicalTrials.gov,检索日期:2026年10月6日。每项研究自行设定入选标准,由研究团队决定谁能参与。